Bavarian Nordic A/S (BVNRY)
OTCMKTS · Delayed Price · Currency is USD
9.76
-0.10 (-1.01%)
Dec 24, 2025, 4:00 PM EST
Bavarian Nordic Revenue
Bavarian Nordic had revenue of 1.79B DKK in the quarter ending September 30, 2025, with 31.65% growth. This brings the company's revenue in the last twelve months to 6.89B, up 13.47% year-over-year. In the year 2024, Bavarian Nordic had annual revenue of 5.72B, down -19.06%.
Revenue (ttm)
6.89B DKK
Revenue Growth
+13.47%
P/S Ratio
2.16
Revenue / Employee
4.29M DKK
Employees
1,605
Market Cap
2.34B USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.72B | -1.35B | -19.06% |
| Dec 31, 2023 | 7.06B | 3.91B | 124.14% |
| Dec 31, 2022 | 3.15B | 1.25B | 66.02% |
| Dec 31, 2021 | 1.90B | 45.49M | 2.46% |
| Dec 31, 2020 | 1.85B | 1.19B | 179.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Northwest Biotherapeutics | 937.00K |
Bavarian Nordic News
- 8 days ago - Bavarian Nordic Establishes Long-term Incentive Program for Members of Executive Management and Selected Employees - GlobeNewsWire
- 9 days ago - Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic - GlobeNewsWire
- 14 days ago - Bavarian Nordic A/S (BVNRY) Shareholder/Analyst Call - Slideshow - Seeking Alpha
- 24 days ago - Bavarian Nordic to Launch Share Buy-back Program of up to DKK 500 Million - GlobeNewsWire
- 6 weeks ago - Bavarian Nordic AS (BVNKF) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... - GuruFocus
- 6 weeks ago - Bavarian Nordic A/S 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 6 weeks ago - Bavarian Nordic A/S (BVNRY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Bavarian Nordic A/S reports Q3 results; updates FY outlook - Seeking Alpha